TAM
GOSS icon

Tiverton Asset Management’s Gossamer Bio GOSS Stock Holding History

Tiverton Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$587K Hold
34,943
– – 0.02% 367
2019
Q2 		$775K Sell
34,943
-8,282
-19% -$158K 0.03% 304
2019
Q1 		$937K Buy
+43,225
New +$901K 0.04% 249

Other funds holding GOSS

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tiverton Asset Management's GOSS Position: Q3 2019 in Review

Tiverton Asset Management held its Gossamer Bio (GOSS) position steady in Q3 2019 at 34,943 shares worth $587K. The position accounts for 0.02% of the portfolio, ranked #367.

Tiverton Asset Management first reported a position in GOSS in Q1 2019 and has held it in 3 quarters since. The position peaked at $937K in Q1 2019. 79 funds tracked by Wall St. Rank hold GOSS as of Q3 2019.

  • Tiverton Asset Management held 34,943 shares of Gossamer Bio worth $587K as of Q3 2019.
  • Tiverton Asset Management left its Gossamer Bio share count unchanged in Q3 2019.
  • Gossamer Bio made up 0.02% of Tiverton Asset Management's portfolio in Q3 2019, its #367 holding.
  • Tiverton Asset Management first reported a position in Gossamer Bio in Q1 2019 and has held it in 3 quarters since.
  • Tiverton Asset Management's Gossamer Bio position peaked at $937K in Q1 2019.
  • 79 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.